Systematic screening of Clorox Co (CLX) reveals a defensive consumer products operator trading at substantial financial stress levels, with shares priced at $92.82—roughly 32% below the 52-week high of $136.69. The company's debt-to-equity ratio of 7.86 flags considerable leverage relative to the shareholder base, while the current ratio of 0.84 indicates near-term liquidity constraints that distinguish CLX from typical blue-chip consumer staples profiles.

The profitability architecture presents notable characteristics. ROE registers at 453.68%, a mathematically inflated figure resulting from negative shareholder equity—a direct consequence of the elevated debt load. More meaningful operational metrics include ROI of 23.37% and ROA of 13.07%, suggesting underlying business efficiency despite balance sheet pressures. The operating margin of 14.62% and net margin of 11.18% reflect sustained pricing power in branded household essentials, while the gross margin of 43.85% demonstrates manufacturing scale advantages.

Revenue contraction of 3.69% year-over-year contrasts with EPS growth of 10.56%, indicating margin expansion and cost discipline offsetting topline headwinds. The trailing P/E of 14.8 represents a significant discount to historical consumer staples valuations, though the P/B ratio of 46.1 underscores the equity base erosion. The beta of 0.57 confirms defensive characteristics during market volatility.

Relative to peers including Procter & Gamble (PG), Colgate-Palmolive (CL), and Kimberly-Clark (KMB), fundamental screening positions CLX as a distressed turnaround scenario rather than a traditional stable staples play. The leverage profile and liquidity metrics differentiate risk-return parameters substantially from its peer cohort, warranting distinct analytical frameworks for portfolio consideration.